Characterization and Biodistribution of REGENXBIO NAV Platform Capsids: Under-Employed Gene Therapy Vector AAV7

Explore a 33-minute webinar presented by Dr. Samantha Yost on the characterization and biodistribution of REGENXBIO NAV® platform capsids, focusing on the under-employed gene therapy vector AAV7. Delve into the potential of adeno-associated viruses (AAV) as gene delivery vectors for treating severe human diseases. Learn about the properties of less-studied, naturally occurring capsids, including their potency differences, tissue tropism, and reduced immunogenicity. Gain insights from Dr. Yost's expertise in structure-function studies of alphaviral non-structural polyproteins. Discover how to earn PACE credits by watching the webinar and following the provided instructions. Connect with Labroots on various social media platforms for more scientific content and updates.

Characterization and biodistribution of REGENXBIO NAV® platform capsids: under-employed gene...